We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Chewy Inc | NYSE:CHWY | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-1.02 | -6.22% | 15.38 | 16.59 | 15.27 | 16.50 | 8,332,747 | 00:58:01 |
By Dean Seal
Chewy and eight other manufacturers and distributors of antimicrobial animal drugs have received warning letters from the Food and Drug Administration telling them that those medicines are unapproved and misbranded.
The agency said on Thursday that it's concerned that using the products, which contain antimicrobials that are important in human medicine, without medical oversight contributes to the development of antimicrobial resistance.
The FDA said it hasn't verified the safety or effectiveness of the products as part of an animal drug review process or facility inspections, and that the products are being illegally marketed over the counter. The products are marketed and labeled for minor species such as aquarium fish and pet birds, and contain antimicrobials including amoxicillin and penicillin.
Representatives for Chewy didn't immediately respond to a request for comment.
Among the other companies that received FDA warning letters were Kraft Drug and California Veterinary Supply.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
December 14, 2023 11:19 ET (16:19 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Chewy Chart |
1 Month Chewy Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions